Bruker Announces Major Advances in CCS-Enabled 4D Proteomics at ASMS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Bruker (BRKR) PT Raised to $90 at Cowen
November 3, 2021 6:36 AM EDTCowen analyst Max Masucci raised the price target on Bruker (NASDAQ: BRKR) to $90.00 (from $68.00) while maintaining a Market Perform rating.
The analyst commented, "BRKR delivered a solid Q3 update and raised its FY'21 guide for the third time this year. Valuation... More
